Fig. 5. Colistin peak and trough plasma concentrations measured at day 2 and day 3 of treatment with nebulized colistin either in monotherapy (n = 9) or combined with a 3-day intravenous administration of aminoglycoside (n = 7) in patients of the multidrug-resistant strain group.